Cargando…

The Impact of the Percent of Residual Prostate-Specific Antigen on Metastasis-Free Survival in Patients with Persistent Prostate-Specific Antigen after Radical Prostatectomy

PURPOSE: Persistent levels of prostate-specific antigen (PSA) is a poor prognostic factor for recurrence after radical prostatectomy (RP). We investigated the impact of the percentage of residual PSA (%rPSA) [(post-/preoperative PSA)×100], representing a biochemical residual tumor, and the first pos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Dan Bee, Kim, Jae Yeon, Song, Won Hoon, Nam, Jong Kil, Lee, Hyun Jung, Kim, Tae Un, Park, Sung-Woo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Sexual Medicine and Andrology 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826909/ https://www.ncbi.nlm.nih.gov/pubmed/36047076 http://dx.doi.org/10.5534/wjmh.220066

Ejemplares similares

Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value
por: Chung, Jae Hoon, et al.
Publicado: (2021)

Correction: Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value
por: Chung, Jae Hoon, et al.
Publicado: (2022)

Clinicopathological and oncological significance of persistent prostate-specific antigen after radical prostatectomy: A systematic review and meta-analysis
por: Wu, Shulin, et al.
Publicado: (2023)

Prognostic Significance of Prostate-Specific Antigen Persistence after Radical Prostatectomy: A Systematic Review and Meta-Analysis
por: Kimura, Shoji, et al.
Publicado: (2021)

Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy
por: Mandel, Philipp, et al.
Publicado: (2021)

Risk factors for prostate-specific antigen persistence in pT3aN0 prostate cancer after robot-assisted laparoscopic radical prostatectomy: a retrospective study
por: Kim, Jun Seop, et al.
Publicado: (2023)

Prostate-Specific Antigen Density as a Powerful Predictor of Extracapsular Extension and Positive Surgical Margin in Radical Prostatectomy Patients with Prostate-Specific Antigen Levels of Less than 10 ng/ml
por: Chang, Jin-Seok, et al.
Publicado: (2011)

Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death
por: Tilki, Derya, et al.
Publicado: (2023)

Prostate-specific antigen density as a parameter for the prediction of positive lymph nodes at radical prostatectomy
por: Yiakoumos, Theocharis, et al.
Publicado: (2015)

Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(−1)
por: Chen, Rui, et al.
Publicado: (2015)

Prostate Specific Membrane Antigen mRNA in Blood as a Potential Predictor of Biochemical Recurrence after Radical Prostatectomy
por: Joung, Jae Young, et al.
Publicado: (2010)

Early dutasteride monotherapy in men with detectable serum prostate-specific antigen levels following radical prostatectomy: A prospective trial
por: Shin, Yu Seob, et al.
Publicado: (2017)

Predictive Value of Neutrophil to Lymphocyte Ratio in the Diagnosis of Significant Prostate Cancer at Initial Biopsy: A Comparison with Free Percent Prostate Specific Antigen, Prostate Specific Antigen Density and Primary Circulating Prostate Cells
por: Murray, Nigel P, et al.
Publicado: (2019)

Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomy
por: Laajala, Teemu D., et al.
Publicado: (2016)

Prostate specific antigen (PSA) persistence 6 weeks after radical prostatectomy and pelvic lymph node dissection as predictive factor of radiographic progression in node-positive prostate cancer patients
por: Kim, Jung Kwon, et al.
Publicado: (2019)

Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study
por: Tarantino, Giovanni, et al.
Publicado: (2021)

Pathological predictors of (18)F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy
por: Perry, Elisa, et al.
Publicado: (2022)

Risk prediction models for biochemical recurrence after radical prostatectomy using prostate-specific antigen and Gleason score
por: Hu, Xin-Hai, et al.
Publicado: (2014)

Erratum: Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomy
por: Laajala, Teemu D., et al.
Publicado: (2017)

Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens
por: de Lima, Nelson Gianni, et al.
Publicado: (2013)

A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy
por: Jackson, William C, et al.
Publicado: (2013)

Time to Disease Recurrence Is a Predictor of Metastasis and Mortality in Patients with High-risk Prostate Cancer Who Achieved Undetectable Prostate-specific Antigen Following Robot-assisted Radical Prostatectomy
por: Kim, Do Kyung, et al.
Publicado: (2018)

Prostate specific antigen /
Publicado: (2001)

Progression of Prostate Cancer Despite an Extremely Low Serum Level of Prostate-Specific Antigen
por: Lee, Dong Kil, et al.
Publicado: (2010)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010)

Free Prostate-Specific Antigen Provides More Precise Data on Benign Prostate Volume Than Total Prostate-Specific Antigen in Korean Population
por: Choi, Hoon, et al.
Publicado: (2013)

The use of early postoperative prostate-specific antigen to stratify risk in patients with positive surgical margins after radical prostatectomy
por: Vesely, Stepan, et al.
Publicado: (2014)

Early Dutasteride Monotherapy in Patients With Elevated Serum Prostate-Specific Antigen Levels Following Robot-Assisted Radical Prostatectomy
por: Lu, Chin-Heng, et al.
Publicado: (2019)

Effect of serum testosterone and percent tumor volume on extra-prostatic extension and biochemical recurrence after laparoscopic radical prostatectomy
por: Hwang, Eu Chang, et al.
Publicado: (2016)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

Predictors of survival in prostate cancer patients with bone metastasis and extremely high prostate-specific antigen levels
por: Koo, Kyo Chul, et al.
Publicado: (2015)

Prostate-Specific Antigen and Prostate-Specific Antigen Kinetics in Predicting (18)F-Sodium Fluoride Positron Emission Tomography-Computed Tomography Positivity for First Bone Metastases in Patients with Biochemical Recurrence after Radical Prostatectomy
por: Yoon, James, et al.
Publicado: (2017)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

Prostate stem cell antigen mRNA in blood is a predictor of survival after radical prostatectomy in patients with high-risk prostate cancer
por: Suh, Yoon Seok, et al.
Publicado: (2018)

The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density
por: Chen, Yue, et al.
Publicado: (2019)

The Prostate Cancer Detection Rate on the Second Prostate Biopsy according to Prostate-Specific Antigen Trend
por: Kim, Hyung-Sang, et al.
Publicado: (2012)

The presence of prostate-specific antigen checked more than 1 year before diagnostic biopsy is an independent prognostic factor in patients undergoing radical prostatectomy
por: Park, Sung Gon, et al.
Publicado: (2021)

Expression of Neutral Endopeptidase, Endothelin-1, and Nuclear Factor Kappa B in Prostate Cancer: Interrelations and Associations with Prostate-Specific Antigen Recurrence after Radical Prostatectomy
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2012)

Prostate cancer risk prediction based on clinical factors and prostate-specific antigen
por: Hwang, Taewon, et al.
Publicado: (2023)

In Search of a New Prostate-Specific Antigen
por: Kim, Jin Wook
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rs0upmlmup4atu9jvs6862o1vp